发明授权
US5028692A Gastrin releasing peptide antagonist 失效
胃泌素释放肽拮抗剂

Gastrin releasing peptide antagonist
摘要:
Small cell lung carcinoma cells (SCLC) contain gastrin releasing peptide (GRP) receptors. The response of the cells to GRP is rapid growth. We have found a group of peptide derivatives that act as GRP antagonists by blocking the binding of GRP to its receptor thereby inhibiting the growth of cells that are sensitive to the growth promoting activity of GRP.
公开/授权文献
信息查询
0/0